Source: Annual Congress 2012 - PG9 Progress on the treatment of COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
P.J. Barnes (London, United Kingdom). Changes in the anti-inflammatory treatment of COPD. Annual Congress 2012 - PG9 Progress on the treatment of COPD

Member's Comments

No comment yet.

Related content which might interest you: Next generation of anti-inflammatory therapy for COPD? Source: Eur Respir J, 50 (4) 1702084; 10.1183/13993003.02084-2017 Year: 2017 Effect of low dose theophylline as adjunct in treatment of COPD Source: International Congress 2016 – Pharmacological management of COPD Year: 2016 Effects of anti-inflammatory treatment on inflammatory infiltrate and ventilation parameters in patients with moderate COPD Source: Eur Respir J 2007; 30: Suppl. 51, 141s Year: 2007 Pharmacogenetics of anti-inflammatory treatment in children with asthma Source: Annual Congress 2013 –Towards personalised medicine in respiratory diseases in children Year: 2013 Update on anti-inflammatory therapy in asthma Source: Research Seminar 2012 - Pulmonary inflammation in paediatric respiratory disease Year: 2012 Monitoring anti-inflammatory treatments in IPF and related disorders Source: Annual Congress 2004 - Pathobiological methodologies in monitoring immunomodulatory treatments Year: 2004 Anti-inflammatory effects of add-on atorvastatin therapy during the treatment of COPD patients Source: Annual Congress 2012 - Trials in COPD: novel treatments and insights Year: 2012 The mechanisms of antiinflammatory effect of mucolytic therapy Source: International Congress 2014 – Predictors Year: 2014 The effect of statin therapy in patients with chronic obstructive airway disease Source: International Congress 2015 – COPD: notable points Year: 2015 Azithromycin in the anti-inflammatory treatment of children with asthma Source: Eur Respir J 2004; 24: Suppl. 48, 167s Year: 2004 Mucolytics and anti-inflammatory lung treatments Source: ERS course 2015 Year: 2015 Effect of roflumilast on exacerbations in patients with severe COPD and a prior history of hospitalization taking combination therapy Source: International Congress 2015 – Advances in the future treatment of COPD Year: 2015 Anti-inflammatory effects of targeted lung denervation in patients with COPD Source: Eur Respir J 2015; 46: 1489-1492 Year: 2015 The role of proinflammatory cytokines in severe COPD patients before and after roflumilast treatment Source: International Congress 2016 – Novel avenues in the treatment of COPD II Year: 2016 Changes in EBC cytokine pattern during treatment of COPD exacerbation Source: Annual Congress 2009 - Cell biology of lung disease Year: 2009 Effects of dexamethasone and anti-inflammatory drugs on inflammatory cytokines from bronchial epithelial cells of COPD patients Source: International Congress 2015 – New insights into lung disease pathogenesis Year: 2015 Effects of a single inhaled budesonide/formoterol dose on glucocorticoid receptor activity in sputum of COPD patients Source: International Congress 2016 – Novel insights into the treatment of COPD Year: 2016 Plasma biomarkers and response to therapy at exacerbation of COPD Source: Eur Respir J 2007; 30: Suppl. 51, 39s Year: 2007